CME vs LIN · P/E 22, rev $6.52B vs P/E 34, rev $33.99B
CME Group Inc (CME) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
CME currently screens at market cap $91.25B and trailing P/E 21.9. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the CME and LIN stock pages for the full models.
Not investment advice.